[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

IN2013MU03843A - - Google Patents

Download PDF

Info

Publication number
IN2013MU03843A
IN2013MU03843A IN3843MU2013A IN2013MU03843A IN 2013MU03843 A IN2013MU03843 A IN 2013MU03843A IN 3843MU2013 A IN3843MU2013 A IN 3843MU2013A IN 2013MU03843 A IN2013MU03843 A IN 2013MU03843A
Authority
IN
India
Prior art keywords
benzyl
methylpiperidin
methylamine
methanol
pyridine
Prior art date
Application number
Other languages
English (en)
Inventor
G Sathe Dr Dhananjay
Das Dr Arijit
Subhash Patil Yogesh
L Bonde Dr Nilesh
Sampat Kekan Ankush
Original Assignee
Unichem Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to PT191509728T priority Critical patent/PT3539965T/pt
Priority to EP19150972.8A priority patent/EP3539965B1/en
Application filed by Unichem Lab Ltd filed Critical Unichem Lab Ltd
Priority to PT14869304T priority patent/PT2994454T/pt
Priority to PL14869304T priority patent/PL2994454T3/pl
Priority to EP14869304.7A priority patent/EP2994454B1/en
Priority to TR2019/04767T priority patent/TR201904767T4/tr
Priority to HUE14869304A priority patent/HUE042911T2/hu
Priority to HUE19150972A priority patent/HUE053975T2/hu
Priority to JP2016557204A priority patent/JP6368794B2/ja
Priority to MX2015015432A priority patent/MX362290B/es
Priority to US14/891,028 priority patent/US9951012B2/en
Priority to ES14869304T priority patent/ES2720066T3/es
Priority to SI201431805T priority patent/SI3539965T1/sl
Priority to IN3843MU2013 priority patent/IN2013MU03843A/en
Priority to BR112015025543-4A priority patent/BR112015025543B1/pt
Priority to ES19150972T priority patent/ES2865058T3/es
Priority to PL19150972T priority patent/PL3539965T3/pl
Priority to SI201431159T priority patent/SI2994454T1/sl
Priority to PCT/IB2014/066510 priority patent/WO2015087201A1/en
Publication of IN2013MU03843A publication Critical patent/IN2013MU03843A/en
Priority to ZA2015/06551A priority patent/ZA201506551B/en
Priority to US15/590,408 priority patent/US20170240510A1/en
Priority to US15/786,195 priority patent/US20180037551A1/en
Priority to US15/868,331 priority patent/US10829450B2/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/02Preparation by ring-closure or hydrogenation
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/92Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with a hetero atom directly attached to the ring nitrogen atom
    • C07D211/98Nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/74Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/75Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
IN3843MU2013 2013-12-09 2014-12-02 IN2013MU03843A (pt)

Priority Applications (23)

Application Number Priority Date Filing Date Title
SI201431805T SI3539965T1 (sl) 2013-12-09 2014-12-02 Izboljšan postopek za pripravo (3R,4R)-(1-benzil-4-metilpiperidin-3-il)-metilamina
ES14869304T ES2720066T3 (es) 2013-12-09 2014-12-02 Mejora del proceso de preparación de (3R,4R)-(1-bencil-4-metilpiperidín-3-il)-metilamina
PT14869304T PT2994454T (pt) 2013-12-09 2014-12-02 Um processo melhorado para a preparacao de (3r,4r)-(1-benzil-4- metilpiperidin-3-il)-metilamina
EP19150972.8A EP3539965B1 (en) 2013-12-09 2014-12-02 An improved process for the preparation of (3r,4r)-(1-benzyl-4-methylpiperidin-3-yl)-methylamine
EP14869304.7A EP2994454B1 (en) 2013-12-09 2014-12-02 An improved process for the preparation of (3r,4r)-(1-benzyl-4-methylpiperidin-3-yl)-methylamine
TR2019/04767T TR201904767T4 (tr) 2013-12-09 2014-12-02 (3R,4R)-(1-benzil-4-metilpiperidin-3-il)-metilamin hazırlanması için geliştirilmiş bir işlem.
IN3843MU2013 IN2013MU03843A (pt) 2013-12-09 2014-12-02
HUE19150972A HUE053975T2 (hu) 2013-12-09 2014-12-02 Továbbfejlesztett eljárás (3R,4R)-(1-benzil-4-metilpiperidin-3-il)-metilamin elõállítására
JP2016557204A JP6368794B2 (ja) 2013-12-09 2014-12-02 (3r,4r)−(1−ベンジル−4−メチルピペリジン−3−イル)−メチルアミンの改良された調製方法
MX2015015432A MX362290B (es) 2013-12-09 2014-12-02 Un proceso mejorado para la preparacion de (3r,4r)-(1-bencilo-4-me tilpiperidina-3-il)-metilamina.
US14/891,028 US9951012B2 (en) 2013-12-09 2014-12-02 Process for the preparation of (3R,4R)-(1-benzyl-4-methylpiperidin-3-yl)-methylamine
PT191509728T PT3539965T (pt) 2013-12-09 2014-12-02 Processo melhorado para a preparação de (3r,4r)-(1-benzil-4-metilpiperidin-3-il)-metilamina
PL14869304T PL2994454T3 (pl) 2013-12-09 2014-12-02 Ulepszony sposób wytwarzania (3R,4R)-(1-benzylo-4-metylopiperydyn-3-ylo)metyloaminy
HUE14869304A HUE042911T2 (hu) 2013-12-09 2014-12-02 Javított eljárás a (3R,4R)-(1-benzil-4-metil-piperidin-3-il)-metilamin elõállítására
BR112015025543-4A BR112015025543B1 (pt) 2013-12-09 2014-12-02 processo para a preparação de (3r,4r)-(1-benzil-4- metilpiperidina-3-il)-metilamina e compostos intermediários
ES19150972T ES2865058T3 (es) 2013-12-09 2014-12-02 Un proceso mejorado para la preparación de (3R,4R)-(1-bencil-4-metilpiperidin-3-il)-metilamina
PL19150972T PL3539965T3 (pl) 2013-12-09 2014-12-02 Ulepszony sposób wytwarzania (3r,4r)-(1-benzylo-4-mety-lopiperydyn-3-ylo)metyloaminy
SI201431159T SI2994454T1 (sl) 2013-12-09 2014-12-02 Izboljšan postopek za pripravo (3R,4R)-(1-benzil-4-metil piperidin-3-il)-metil amina
PCT/IB2014/066510 WO2015087201A1 (en) 2013-12-09 2014-12-02 An improved process for the preparation of (3r,4r)-(1-benzyl-4-methylpiperidin-3-yl)-methylamine
ZA2015/06551A ZA201506551B (en) 2013-12-09 2015-09-04 An improved process for the preparation of (3r,4r)-(1-benzyl-4-methylpiperidin-3-yl)-methylamine
US15/590,408 US20170240510A1 (en) 2013-12-09 2017-05-09 Process for the preparation of (3r,4r)-(1-benzyl-4-methylpiperidin-3-yl)-methylamine
US15/786,195 US20180037551A1 (en) 2013-12-09 2017-10-17 Process for the Preparation of (3R,4R)-(1-BENZYL-4-METHYLPIPERIDIN-3-YL)-METHYLAMINE
US15/868,331 US10829450B2 (en) 2013-12-09 2018-01-11 Process for the preparation of (3R,4R)-(1-benzyl-4-methylpiperidin-3-yl)-methylamine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN3843MU2013 IN2013MU03843A (pt) 2013-12-09 2014-12-02

Publications (1)

Publication Number Publication Date
IN2013MU03843A true IN2013MU03843A (pt) 2015-08-14

Family

ID=53370688

Family Applications (1)

Application Number Title Priority Date Filing Date
IN3843MU2013 IN2013MU03843A (pt) 2013-12-09 2014-12-02

Country Status (14)

Country Link
US (4) US9951012B2 (pt)
EP (2) EP3539965B1 (pt)
JP (1) JP6368794B2 (pt)
BR (1) BR112015025543B1 (pt)
ES (2) ES2865058T3 (pt)
HU (2) HUE042911T2 (pt)
IN (1) IN2013MU03843A (pt)
MX (1) MX362290B (pt)
PL (2) PL2994454T3 (pt)
PT (2) PT3539965T (pt)
SI (2) SI2994454T1 (pt)
TR (1) TR201904767T4 (pt)
WO (1) WO2015087201A1 (pt)
ZA (1) ZA201506551B (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN2013MU03843A (pt) * 2013-12-09 2015-08-14 Unichem Lab Ltd
PL3248980T3 (pl) 2015-01-20 2024-03-04 Wuxi Fortune Pharmaceutical Co., Ltd Inhibitor jak
MX370933B (es) 2015-04-29 2020-01-09 Wuxi Fortune Pharmaceuticals Co Ltd Inhibidores jak.
AU2016271904B2 (en) 2015-05-29 2018-05-10 Wuxi Fortune Pharmaceutical Co.,Ltd Janus kinase inhibitor
CN105237463B (zh) * 2015-10-09 2017-10-10 刘卫国 一种(3r,4r)‑(1‑苄基‑4‑甲基哌啶‑3‑基)甲胺‑l‑二对甲苯甲酰酒石酸盐的制备方法
CN105884781B (zh) * 2016-04-18 2018-04-20 山东罗欣药业集团股份有限公司 一种枸橼酸托法替布的制备方法
EP3301087A1 (en) * 2016-09-30 2018-04-04 DPx Fine Chemicals Austria GmbH & Co KG Process for preparing chiral amines
CN107056681B (zh) * 2017-03-30 2019-10-01 广州白云山光华制药股份有限公司 一种托法替布中间体的制备方法
CN110668995A (zh) * 2018-07-03 2020-01-10 江苏海悦康医药科技有限公司 一种枸橼酸托法替布中间体及枸橼酸托法替布的制备方法
CN114685515A (zh) * 2022-03-15 2022-07-01 上海蓝乐鸟实业有限公司 一种托法替尼的制备方法
CN115872923B (zh) * 2022-12-29 2023-04-28 成都泰和伟业生物科技有限公司 一种化合物及其制备方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06145144A (ja) 1992-11-04 1994-05-24 Ihara Chem Ind Co Ltd 新規な3−アミノピリジン誘導体第4級アンモニウム塩及びこれを有効成分とする抗癌剤
JP4671079B2 (ja) * 1999-07-05 2011-04-13 日本農薬株式会社 フタラミド誘導体、その中間体及び農園芸用殺虫剤並びにその使用方法
JP3943394B2 (ja) * 1999-10-20 2007-07-11 田辺製薬株式会社 αLβ2介在細胞接着阻害剤
ES2208433T3 (es) 1999-12-10 2004-06-16 Pfizer Products Inc. Compuestos de pirrolo(2,3-d)pirimidina como inhibidores de proteina quinasas.
NZ528216A (en) 2001-02-24 2006-12-22 Boehringer Ingelheim Pharma Xanthine derivatives, the preparation thereof and their use as pharmaceutical compositions
US7301023B2 (en) * 2001-05-31 2007-11-27 Pfizer Inc. Chiral salt resolution
GT200200234A (es) * 2001-12-06 2003-06-27 Compuestos cristalinos novedosos
AU2005317870A1 (en) * 2004-12-22 2006-06-29 Astrazeneca Ab Pyridine carboxamide derivatives for use as anticancer agents
WO2007012953A2 (en) 2005-07-29 2007-02-01 Pfizer Products Inc. Pyrrolo[2,3-d]pyrimidine derivatives; their intermediates and synthesis
WO2008029237A2 (en) * 2006-09-05 2008-03-13 Pfizer Products Inc. Combination therapies for rheumatoid arthritis
RU2011105768A (ru) * 2008-08-01 2012-09-10 Биокрист Фармасьютикалз, Инк. (Us) Производные пиперидина в качестве ингибиторов jakз
MX2011010923A (es) 2009-04-14 2011-11-18 Astellas Pharma Inc Derivado de pirrolopiridina condensado.
BRPI1007737A2 (pt) 2009-04-20 2015-09-01 Auspex Pharmaceuticals Llc "composto da fórmula estrutural i, composição farmacêutica, método de tratamento de um distúbio mediano por janus quinase 3, método de preparação de um composto da fórmula estrutural ii, e método de preparação de um composto da fórmula estrutural xii"
CA2768373A1 (en) * 2009-07-21 2011-01-27 The Board Of Trustees Of The Leland Stanford Junior University Heteroaryl benzamides, compositions and methods of use
KR20120081609A (ko) * 2009-09-29 2012-07-19 글락소 그룹 리미티드 신규 화합물
IN2013MU03843A (pt) * 2013-12-09 2015-08-14 Unichem Lab Ltd

Also Published As

Publication number Publication date
US10829450B2 (en) 2020-11-10
ZA201506551B (en) 2017-02-22
MX2015015432A (es) 2016-03-15
EP3539965B1 (en) 2021-01-20
ES2865058T3 (es) 2021-10-14
SI2994454T1 (sl) 2019-05-31
JP2017503007A (ja) 2017-01-26
MX362290B (es) 2019-01-10
US20180037551A1 (en) 2018-02-08
BR112015025543A2 (pt) 2017-07-18
PT2994454T (pt) 2019-04-02
WO2015087201A1 (en) 2015-06-18
EP2994454A4 (en) 2016-12-21
US9951012B2 (en) 2018-04-24
PL3539965T3 (pl) 2021-07-05
JP6368794B2 (ja) 2018-08-01
US20170240510A1 (en) 2017-08-24
EP3539965A1 (en) 2019-09-18
US20180134661A1 (en) 2018-05-17
PT3539965T (pt) 2021-04-07
BR112015025543B1 (pt) 2020-11-03
SI3539965T1 (sl) 2021-07-30
TR201904767T4 (tr) 2019-05-21
HUE042911T2 (hu) 2019-07-29
PL2994454T3 (pl) 2019-09-30
US20160102057A1 (en) 2016-04-14
EP2994454B1 (en) 2019-03-06
ES2720066T3 (es) 2019-07-17
EP2994454A1 (en) 2016-03-16
HUE053975T2 (hu) 2021-08-30

Similar Documents

Publication Publication Date Title
IN2013MU03843A (pt)
MY156546A (en) Process for the regioselective preparation of 1-alkyl-3-haloalkylpyrazole-4-carboxylic acid derivatives
MY201120A (en) Intermediates for use in a process of producing pyrrole compounds
JOP20160185B1 (ar) طريقة لتحضير (4s)-4-(4- سيانو-2- ميثوكسي فنيل)-5- إيثوكسي-8،2-داي ميثيل-4،1-داي هيدرو-6،1- نافثيريدين-3- كربوكساميد واسترجاع (4s)-4-(4- سيانو-2- ميثوكسي فنيل)-5- إيثوكسي-8،2- داي ميثيل-4،1- داي هيدرو-6،1- نافثيريدين-3- كربوكساميد بواسطة طرق كهروكيميائية
SA515361251B1 (ar) طريقة لزيادة تكوين حمض بيرو-جلوتاميك من بروتين
WO2009114438A3 (en) Cyclohexanedimethanamine by direct amination of cyclohexanedimethanol
WO2013121436A3 (en) A process for preparation of rivaroxaban and intermediates thereof
MX2018014050A (es) Precursor de dioxoxido de cloro y metodos de uso del mismo.
MX2014014138A (es) Procedimiento nuevo para la preparacion de acido 2-ciclopentil-6-metoxi-isonicotinico.
WO2014057498A3 (en) Process for the preparation of cobicistat intermediates
UA112331C2 (uk) Композиція, що містить блок-співконденсати пропіл-функціоналізованих силіконатів і силікатів лужних металів, а також спосіб їх одержання
EP2463266A4 (en) PROCESS FOR PRODUCING BIS-QUATERNARY AMMONIUM SALT, AND NOVEL INTERMEDIATE
HK1163659A1 (en) Process for the preparation of ajoene
MX337357B (es) Excipiente para tableteado a base de lactosa y celulosa.
EA201200820A1 (ru) Способ синтеза промежуточных продуктов, применимых для получения замещенных индазолов и азаиндазолов
UA106724C2 (uk) Спосіб отримання заміщених піримідинових похідних
MX2010009931A (es) Proceso para la preparacion de 2-amino-2-[2-(4-c3-c21-alquil-fenil )-etil]-propano-1,3-dioles.
MY163020A (en) A process for the preparation of etoricoxib
WO2011027359A3 (en) Process for the preparation of 4 -hydroxy atomoxetine and intermediates in the manufacture thereof
MX2015003237A (es) Metodos para producir molindona y sus sales.
MX2013006017A (es) Separacion de enantiomeros derivados de triazina usando acido tartarico.
MX2014004847A (es) Procedimiento para la preparacion y estabilizacion de composiciones de policarbonato modificadas al impacto usando disoluciones diluidas de compuestos acidos.
BR112015009139A2 (pt) processo de produção de soforose a partir de soforolipídios
WO2013072766A3 (en) Process for cabazitaxel and intermediates thereof
EA201101613A1 (ru) Способ получения севеламера